Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs*
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 31 (9) , 2339-2343
- https://doi.org/10.1097/01.ccm.0000084844.95073.c0
Abstract
Levosimendan is a promising calcium sensitizer that potentially could be useful in settings of pulmonary vasoconstriction and right ventricular dysfunction. There is a shortage of information concerning its effects on right ventricular function and ventriculovascular coupling. The aim of the present study was to characterize the effects of levosimendan on right ventricular and pulmonary vascular function by means of pressure-volume and pulsatile flow analysis. Prospective laboratory investigation. University hospital laboratory Eight landrace pigs (mean weight, 37 kg). Following instrumentation with biventricular conductance catheters, pulmonary and right coronary artery flow probes, a high-fidelity pulmonary pressure catheter, and a right coronary venous catheter, hemodynamic measurements were performed in baseline conditions and during levosimendan infusion at three increasing plasma concentrations (mean values, 27.5, 67.6, and 142.5 ng/mL). Levosimendan increased heart rate and cardiac output, reduced systemic vascular resistance, and had a positive inotropic effect on the left ventricle and increased left ventricular mechanical efficiency. Moreover, levosimendan increased right ventricular contractility and hydraulic power. However, total pulmonary vascular resistance and characteristic impedance did not change throughout the protocol, and right ventricular mechanical efficiency decreased slightly at the highest concentration of levosimendan. At clinical concentrations in the present model, levosimendan increases right ventricular contractility and performance without significantly influencing pulmonary vascular tone. Further studies are required in a model of pulmonary vasoconstriction to disclose possible pulmonary vasodilator effects of levosimendan.Keywords
This publication has 21 references indexed in Scilit:
- Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension*Critical Care Medicine, 2002
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shockCritical Care Medicine, 2001
- Levosimendan, a New Positive Inotropic Drug, Decreases Myocardial Infarct Size via Activation of KATP ChannelsAnesthesia & Analgesia, 2000
- Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytesEuropean Journal of Pharmacology, 1997
- Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiencyBasic Research in Cardiology, 1996
- Levosimendan (OR-1259), a Myofilament Calcium Sensitizer, Enhances Myocardial Contractility but Does Not Alter Isovolumic Relaxation in Conscious and Anesthetized DogsAnesthesiology, 1994
- The use of left ventricular end-ejection pressure and peak pressure in the estimation of the end-systolic pressure-volume relationship.Circulation, 1984
- Continuous measurement of left ventricular volume in animals and humans by conductance catheter.Circulation, 1984
- Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart.Circulation Research, 1981